

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.76203309 |
| 2 | cullin deneddylation (GO:0010388) | 4.74103484 |
| 3 | protein deneddylation (GO:0000338) | 4.56412486 |
| 4 | chaperone-mediated protein transport (GO:0072321) | 4.52849595 |
| 5 | protein complex biogenesis (GO:0070271) | 4.52393657 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.50788874 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 4.50788874 |
| 8 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.50788874 |
| 9 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.42265679 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.33224617 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.33224617 |
| 12 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.29049858 |
| 13 | proteasome assembly (GO:0043248) | 4.28139589 |
| 14 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.18650435 |
| 15 | DNA deamination (GO:0045006) | 4.00431152 |
| 16 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.97456327 |
| 17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83965139 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 3.76611531 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.76611531 |
| 20 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.75471087 |
| 21 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.75471087 |
| 22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74222663 |
| 23 | regulation of mitochondrial translation (GO:0070129) | 3.67243386 |
| 24 | negative regulation of mast cell activation (GO:0033004) | 3.66647763 |
| 25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.58799052 |
| 26 | * 7-methylguanosine mRNA capping (GO:0006370) | 3.58128248 |
| 27 | respiratory chain complex IV assembly (GO:0008535) | 3.57868685 |
| 28 | establishment of integrated proviral latency (GO:0075713) | 3.53361542 |
| 29 | * RNA capping (GO:0036260) | 3.52483406 |
| 30 | * 7-methylguanosine RNA capping (GO:0009452) | 3.52483406 |
| 31 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.51043783 |
| 32 | purine nucleobase biosynthetic process (GO:0009113) | 3.50407759 |
| 33 | respiratory electron transport chain (GO:0022904) | 3.49560037 |
| 34 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.48032185 |
| 35 | nucleobase biosynthetic process (GO:0046112) | 3.47948707 |
| 36 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.46939876 |
| 37 | protein neddylation (GO:0045116) | 3.45202030 |
| 38 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.43403192 |
| 39 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.43334792 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.42472950 |
| 41 | protein-cofactor linkage (GO:0018065) | 3.42116957 |
| 42 | electron transport chain (GO:0022900) | 3.41401078 |
| 43 | oxidative phosphorylation (GO:0006119) | 3.41308674 |
| 44 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.41110409 |
| 45 | mannosylation (GO:0097502) | 3.41034451 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.40351890 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.40351890 |
| 48 | peptidyl-histidine modification (GO:0018202) | 3.40323922 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.35912024 |
| 50 | metallo-sulfur cluster assembly (GO:0031163) | 3.35154740 |
| 51 | iron-sulfur cluster assembly (GO:0016226) | 3.35154740 |
| 52 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35146238 |
| 53 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.31285364 |
| 54 | DNA strand elongation (GO:0022616) | 3.30294623 |
| 55 | cytochrome complex assembly (GO:0017004) | 3.29452444 |
| 56 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.29281836 |
| 57 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.29281836 |
| 58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.27021226 |
| 59 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.27021226 |
| 60 | organelle disassembly (GO:1903008) | 3.26804100 |
| 61 | telomere maintenance via recombination (GO:0000722) | 3.26226912 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.25232073 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.25232073 |
| 64 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.25232073 |
| 65 | neural tube formation (GO:0001841) | 3.23990894 |
| 66 | amino acid salvage (GO:0043102) | 3.23516385 |
| 67 | L-methionine salvage (GO:0071267) | 3.23516385 |
| 68 | L-methionine biosynthetic process (GO:0071265) | 3.23516385 |
| 69 | DNA replication initiation (GO:0006270) | 3.22067253 |
| 70 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.22000054 |
| 71 | CENP-A containing nucleosome assembly (GO:0034080) | 3.21932950 |
| 72 | ribosomal small subunit assembly (GO:0000028) | 3.19613705 |
| 73 | centriole replication (GO:0007099) | 3.19567555 |
| 74 | dopamine transport (GO:0015872) | 3.19343688 |
| 75 | maturation of 5.8S rRNA (GO:0000460) | 3.18462123 |
| 76 | viral mRNA export from host cell nucleus (GO:0046784) | 3.18326642 |
| 77 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.17006566 |
| 78 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.17006566 |
| 79 | isotype switching (GO:0045190) | 3.17006566 |
| 80 | protein targeting to mitochondrion (GO:0006626) | 3.16421382 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11431861 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11431861 |
| 83 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.11287017 |
| 84 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.11287017 |
| 85 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.08890010 |
| 86 | establishment of protein localization to mitochondrion (GO:0072655) | 3.08432696 |
| 87 | signal peptide processing (GO:0006465) | 3.06416945 |
| 88 | DNA replication checkpoint (GO:0000076) | 3.04636276 |
| 89 | chromatin remodeling at centromere (GO:0031055) | 3.04510616 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04354710 |
| 91 | GPI anchor metabolic process (GO:0006505) | 3.02433413 |
| 92 | establishment of viral latency (GO:0019043) | 3.01206754 |
| 93 | GTP biosynthetic process (GO:0006183) | 2.99762041 |
| 94 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97845464 |
| 95 | positive regulation of mRNA catabolic process (GO:0061014) | 2.97828734 |
| 96 | replication fork processing (GO:0031297) | 2.97568732 |
| 97 | aerobic respiration (GO:0009060) | 2.95387152 |
| 98 | histone mRNA metabolic process (GO:0008334) | 2.95106524 |
| 99 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93286462 |
| 100 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.93073419 |
| 101 | * transcription-coupled nucleotide-excision repair (GO:0006283) | 2.91629095 |
| 102 | positive regulation of mRNA metabolic process (GO:1903313) | 2.90531753 |
| 103 | mitotic recombination (GO:0006312) | 2.88615988 |
| 104 | cellular component biogenesis (GO:0044085) | 2.88293765 |
| 105 | rRNA modification (GO:0000154) | 2.87544178 |
| 106 | protein localization to mitochondrion (GO:0070585) | 2.87535923 |
| 107 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.87246159 |
| 108 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.87246159 |
| 109 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.86942558 |
| 110 | prenylation (GO:0097354) | 2.84907463 |
| 111 | protein prenylation (GO:0018342) | 2.84907463 |
| 112 | positive regulation of ligase activity (GO:0051351) | 2.82917315 |
| 113 | C-terminal protein lipidation (GO:0006501) | 2.82033350 |
| 114 | ribosomal large subunit biogenesis (GO:0042273) | 2.81654604 |
| 115 | positive regulation of protein homodimerization activity (GO:0090073) | 2.80353209 |
| 116 | rRNA catabolic process (GO:0016075) | 2.80321690 |
| 117 | platelet dense granule organization (GO:0060155) | 2.79895898 |
| 118 | GMP metabolic process (GO:0046037) | 2.79385485 |
| 119 | positive regulation of mRNA processing (GO:0050685) | 2.78785543 |
| 120 | telomere maintenance via telomere lengthening (GO:0010833) | 2.77843995 |
| 121 | double-strand break repair via homologous recombination (GO:0000724) | 2.77801159 |
| 122 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.76989761 |
| 123 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.76989761 |
| 124 | formation of translation preinitiation complex (GO:0001731) | 2.76756125 |
| 125 | DNA double-strand break processing (GO:0000729) | 2.76545623 |
| 126 | ribonucleoprotein complex disassembly (GO:0032988) | 2.76384911 |
| 127 | recombinational repair (GO:0000725) | 2.75867903 |
| 128 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75396431 |
| 129 | spliceosomal snRNP assembly (GO:0000387) | 2.73829757 |
| 130 | ribosome biogenesis (GO:0042254) | 2.71752832 |
| 131 | * G1/S transition of mitotic cell cycle (GO:0000082) | 2.71353408 |
| 132 | * cell cycle G1/S phase transition (GO:0044843) | 2.71353408 |
| 133 | NADH metabolic process (GO:0006734) | 2.70904126 |
| 134 | kinetochore assembly (GO:0051382) | 2.70497979 |
| 135 | neuron cell-cell adhesion (GO:0007158) | 2.70342294 |
| 136 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.69898898 |
| 137 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.67368844 |
| 138 | protein K11-linked deubiquitination (GO:0035871) | 2.66304815 |
| 139 | GPI anchor biosynthetic process (GO:0006506) | 2.65934889 |
| 140 | C-terminal protein amino acid modification (GO:0018410) | 2.65010114 |
| 141 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.63385824 |
| 142 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288) | 2.63318091 |
| 143 | regulation of centriole replication (GO:0046599) | 2.62525715 |
| 144 | DNA ligation (GO:0006266) | 2.61971115 |
| 145 | kinetochore organization (GO:0051383) | 2.61057332 |
| 146 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.59862423 |
| 147 | ribosome assembly (GO:0042255) | 2.59533956 |
| 148 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.57322947 |
| 149 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.54966732 |
| 150 | protein K11-linked ubiquitination (GO:0070979) | 2.54204173 |
| 151 | negative regulation of DNA recombination (GO:0045910) | 2.53440154 |
| 152 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.51804314 |
| 153 | reciprocal DNA recombination (GO:0035825) | 2.50949784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.77657890 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.55138305 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.82891007 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.76383085 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.74756832 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.39142296 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.36055851 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34761559 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.09586845 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.07472323 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.01555474 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.87054088 |
| 13 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.78832412 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65543691 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.61672706 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58443872 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.56422248 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.53225807 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52761396 |
| 20 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.51821430 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.45051203 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37722906 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.37260672 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.33711230 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.31622610 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.31330409 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.24831405 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.18569835 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.13709852 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10290588 |
| 31 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08736793 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06998787 |
| 33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05928892 |
| 34 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.03691583 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.02271636 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.01268794 |
| 37 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.97130281 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96550020 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92272182 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.85431372 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84735821 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84644172 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84104647 |
| 44 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.82971307 |
| 45 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.82619580 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79948531 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79326612 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78358011 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76386911 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68275532 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66442543 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65070281 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64127595 |
| 54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.61803667 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.60310276 |
| 56 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.52383636 |
| 57 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52086809 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50671743 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47771253 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47450943 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45740652 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44455717 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.40820083 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39768431 |
| 65 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37503801 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36618481 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34359040 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32672874 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31086791 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29959698 |
| 71 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28189946 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.24485800 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.22599420 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22116212 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21006364 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21006364 |
| 77 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15751368 |
| 78 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14089163 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13419913 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13241270 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13122721 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12919007 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11024463 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10732959 |
| 85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10406904 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09830775 |
| 87 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08539992 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08534357 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06413342 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06226959 |
| 91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05825805 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05258858 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04654637 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04618650 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04582037 |
| 96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04314022 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03975878 |
| 98 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03946977 |
| 99 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03073569 |
| 100 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02118250 |
| 101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00277171 |
| 102 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99847988 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99492497 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99492497 |
| 105 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98541383 |
| 106 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98434615 |
| 107 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97281552 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97157995 |
| 109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97124441 |
| 110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97077947 |
| 111 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.96812694 |
| 112 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96416625 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96082558 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96022022 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95162438 |
| 116 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94746473 |
| 117 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94403836 |
| 118 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93427296 |
| 119 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93037401 |
| 120 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92989714 |
| 121 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92849996 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92058194 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91649909 |
| 124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91630106 |
| 125 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91617485 |
| 126 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91428797 |
| 127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91349626 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91158270 |
| 129 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90456841 |
| 130 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.90388005 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90220562 |
| 132 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.89243556 |
| 133 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88828477 |
| 134 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.88034783 |
| 135 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.83216194 |
| 136 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.82330457 |
| 137 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81939124 |
| 138 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.81317279 |
| 139 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.80452540 |
| 140 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.80432646 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79898044 |
| 142 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79323310 |
| 143 | JUN_21703547_ChIP-Seq_K562_Human | 0.78255879 |
| 144 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76968986 |
| 145 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76269067 |
| 146 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.75297536 |
| 147 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74235275 |
| 148 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.74225597 |
| 149 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.74093333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.92005767 |
| 2 | MP0003880_abnormal_central_pattern | 3.72873892 |
| 3 | MP0008877_abnormal_DNA_methylation | 3.14697118 |
| 4 | MP0001529_abnormal_vocalization | 3.08671000 |
| 5 | MP0002102_abnormal_ear_morphology | 3.02987910 |
| 6 | MP0010094_abnormal_chromosome_stability | 2.66005024 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.65116353 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.55306663 |
| 9 | MP0008058_abnormal_DNA_repair | 2.49576827 |
| 10 | MP0001188_hyperpigmentation | 2.46352960 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.45234950 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.43289067 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.39595640 |
| 14 | MP0001905_abnormal_dopamine_level | 2.23010034 |
| 15 | MP0009745_abnormal_behavioral_response | 2.15920763 |
| 16 | MP0004147_increased_porphyrin_level | 2.14600692 |
| 17 | MP0009046_muscle_twitch | 2.13083983 |
| 18 | MP0002822_catalepsy | 2.05389491 |
| 19 | MP0002736_abnormal_nociception_after | 2.02114650 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.97966318 |
| 21 | MP0002272_abnormal_nervous_system | 1.97665000 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 1.94448082 |
| 23 | MP0002064_seizures | 1.94192476 |
| 24 | MP0001984_abnormal_olfaction | 1.90567533 |
| 25 | MP0008057_abnormal_DNA_replication | 1.90359140 |
| 26 | MP0003787_abnormal_imprinting | 1.83887624 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.80263062 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.76243160 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.76116361 |
| 30 | MP0003136_yellow_coat_color | 1.76082787 |
| 31 | MP0004142_abnormal_muscle_tone | 1.74866897 |
| 32 | MP0004859_abnormal_synaptic_plasticity | 1.73460371 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.72482675 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.70084350 |
| 35 | MP0003123_paternal_imprinting | 1.69341016 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.69237970 |
| 37 | MP0003786_premature_aging | 1.66697482 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.65921364 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.65833412 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.65808120 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.65436706 |
| 42 | MP0005253_abnormal_eye_physiology | 1.62445069 |
| 43 | MP0001919_abnormal_reproductive_system | 1.62040431 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.60869547 |
| 45 | MP0003077_abnormal_cell_cycle | 1.60546147 |
| 46 | MP0009697_abnormal_copulation | 1.60102843 |
| 47 | MP0005171_absent_coat_pigmentation | 1.57648498 |
| 48 | MP0003121_genomic_imprinting | 1.56530718 |
| 49 | MP0008995_early_reproductive_senescence | 1.55973111 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.51220921 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.49454536 |
| 52 | MP0003122_maternal_imprinting | 1.49183583 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.47527800 |
| 54 | MP0003195_calcinosis | 1.44937884 |
| 55 | MP0003724_increased_susceptibility_to | 1.44334351 |
| 56 | MP0005389_reproductive_system_phenotype | 1.40195543 |
| 57 | MP0001486_abnormal_startle_reflex | 1.39259856 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.37261929 |
| 59 | MP0003718_maternal_effect | 1.31428093 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.29383678 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.29009287 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.27605405 |
| 63 | MP0002067_abnormal_sensory_capabilities | 1.27269534 |
| 64 | MP0000427_abnormal_hair_cycle | 1.26836634 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.24957602 |
| 66 | MP0002095_abnormal_skin_pigmentation | 1.24326666 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.23805145 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.17873095 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.17138028 |
| 70 | MP0004924_abnormal_behavior | 1.17138028 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.15932061 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.12276697 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.08981008 |
| 74 | MP0008260_abnormal_autophagy | 1.08538900 |
| 75 | MP0001764_abnormal_homeostasis | 1.05143657 |
| 76 | MP0002163_abnormal_gland_morphology | 1.04300482 |
| 77 | MP0009379_abnormal_foot_pigmentation | 1.03847504 |
| 78 | MP0001970_abnormal_pain_threshold | 1.02953524 |
| 79 | MP0002009_preneoplasia | 1.01233986 |
| 80 | MP0003879_abnormal_hair_cell | 1.00731462 |
| 81 | MP0002938_white_spotting | 1.00064271 |
| 82 | MP0001800_abnormal_humoral_immune | 0.99801346 |
| 83 | MP0001835_abnormal_antigen_presentation | 0.99184353 |
| 84 | MP0004270_analgesia | 0.97666552 |
| 85 | MP0001440_abnormal_grooming_behavior | 0.97639141 |
| 86 | MP0000689_abnormal_spleen_morphology | 0.96253637 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 0.95826963 |
| 88 | MP0002160_abnormal_reproductive_system | 0.95810295 |
| 89 | MP0005409_darkened_coat_color | 0.94171542 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.93773202 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.92859246 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.92859246 |
| 93 | MP0005266_abnormal_metabolism | 0.92533442 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.92327681 |
| 95 | MP0002184_abnormal_innervation | 0.92214165 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 0.91873226 |
| 97 | MP0002557_abnormal_social/conspecific_i | 0.90739268 |
| 98 | MP0002210_abnormal_sex_determination | 0.89894311 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.89673059 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.88284755 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.88108947 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.87923419 |
| 103 | MP0005499_abnormal_olfactory_system | 0.87848791 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.87848791 |
| 105 | MP0001485_abnormal_pinna_reflex | 0.86872214 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.86840903 |
| 107 | MP0003011_delayed_dark_adaptation | 0.86201145 |
| 108 | MP0003950_abnormal_plasma_membrane | 0.85120890 |
| 109 | MP0001119_abnormal_female_reproductive | 0.83925898 |
| 110 | MP0002398_abnormal_bone_marrow | 0.83179422 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.82191979 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.82032915 |
| 113 | MP0008872_abnormal_physiological_respon | 0.80507974 |
| 114 | MP0005423_abnormal_somatic_nervous | 0.80308510 |
| 115 | MP0008789_abnormal_olfactory_epithelium | 0.79685510 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.79054440 |
| 117 | MP0002733_abnormal_thermal_nociception | 0.77902903 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.77232688 |
| 119 | MP0003646_muscle_fatigue | 0.77113312 |
| 120 | MP0005671_abnormal_response_to | 0.77055470 |
| 121 | MP0004742_abnormal_vestibular_system | 0.76629090 |
| 122 | MP0002723_abnormal_immune_serum | 0.76256802 |
| 123 | MP0002006_tumorigenesis | 0.76055858 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.75546048 |
| 125 | MP0008569_lethality_at_weaning | 0.75143626 |
| 126 | MP0001929_abnormal_gametogenesis | 0.74808654 |
| 127 | MP0001145_abnormal_male_reproductive | 0.73862596 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.73024120 |
| 129 | MP0005000_abnormal_immune_tolerance | 0.72564829 |
| 130 | MP0003698_abnormal_male_reproductive | 0.72560759 |
| 131 | MP0002722_abnormal_immune_system | 0.71693265 |
| 132 | MP0002132_abnormal_respiratory_system | 0.70889644 |
| 133 | MP0005367_renal/urinary_system_phenotyp | 0.70470410 |
| 134 | MP0000516_abnormal_urinary_system | 0.70470410 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.69866775 |
| 136 | MP0000653_abnormal_sex_gland | 0.69472968 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.68607392 |
| 138 | MP0000358_abnormal_cell_content/ | 0.68319978 |
| 139 | MP0002882_abnormal_neuron_morphology | 0.66353327 |
| 140 | MP0001819_abnormal_immune_cell | 0.66150229 |
| 141 | MP0004811_abnormal_neuron_physiology | 0.64966830 |
| 142 | MP0002420_abnormal_adaptive_immunity | 0.64596056 |
| 143 | MP0003186_abnormal_redox_activity | 0.63732668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.32322073 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.00782771 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.77854604 |
| 4 | Increased CSF lactate (HP:0002490) | 4.43685188 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.37330316 |
| 6 | Progressive macrocephaly (HP:0004481) | 4.37170700 |
| 7 | Acute encephalopathy (HP:0006846) | 4.11560425 |
| 8 | Focal motor seizures (HP:0011153) | 3.88779778 |
| 9 | Birth length less than 3rd percentile (HP:0003561) | 3.82473834 |
| 10 | Increased serum pyruvate (HP:0003542) | 3.69963598 |
| 11 | Abnormality of glycolysis (HP:0004366) | 3.69963598 |
| 12 | Hepatic necrosis (HP:0002605) | 3.68109840 |
| 13 | Increased serum lactate (HP:0002151) | 3.26392691 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.22050577 |
| 15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.22050577 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.21134973 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 3.21052189 |
| 18 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.07174436 |
| 19 | Abnormality of alanine metabolism (HP:0010916) | 3.07174436 |
| 20 | Hyperalaninemia (HP:0003348) | 3.07174436 |
| 21 | Lactic acidosis (HP:0003128) | 2.99295180 |
| 22 | Cerebral hypomyelination (HP:0006808) | 2.92587456 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91816602 |
| 24 | Atonic seizures (HP:0010819) | 2.91382703 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.90868201 |
| 26 | Microvesicular hepatic steatosis (HP:0001414) | 2.89360974 |
| 27 | Exercise intolerance (HP:0003546) | 2.89031683 |
| 28 | Abnormal hair whorl (HP:0010721) | 2.88334004 |
| 29 | Methylmalonic aciduria (HP:0012120) | 2.84707440 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 2.82411370 |
| 31 | Molar tooth sign on MRI (HP:0002419) | 2.81916993 |
| 32 | Abnormality of midbrain morphology (HP:0002418) | 2.81916993 |
| 33 | Hypothermia (HP:0002045) | 2.79551513 |
| 34 | Nephrogenic diabetes insipidus (HP:0009806) | 2.78269123 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.77773480 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.77469520 |
| 37 | Respiratory failure (HP:0002878) | 2.75051235 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.73183276 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.72498589 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.71545207 |
| 41 | Gait imbalance (HP:0002141) | 2.70623001 |
| 42 | Optic disc pallor (HP:0000543) | 2.70328610 |
| 43 | IgG deficiency (HP:0004315) | 2.66538477 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.65153310 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.59869818 |
| 46 | Hyperventilation (HP:0002883) | 2.56926831 |
| 47 | Leukodystrophy (HP:0002415) | 2.56830476 |
| 48 | Aplastic anemia (HP:0001915) | 2.56408225 |
| 49 | Pancreatic fibrosis (HP:0100732) | 2.55095012 |
| 50 | Type 2 muscle fiber atrophy (HP:0003554) | 2.55034560 |
| 51 | Renal cortical cysts (HP:0000803) | 2.51327463 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.50538090 |
| 53 | Cerebral edema (HP:0002181) | 2.49112457 |
| 54 | Pheochromocytoma (HP:0002666) | 2.47945415 |
| 55 | Abnormality of the renal cortex (HP:0011035) | 2.46295820 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.42045544 |
| 57 | Respiratory difficulties (HP:0002880) | 2.41178257 |
| 58 | Stomatitis (HP:0010280) | 2.39339368 |
| 59 | Poor suck (HP:0002033) | 2.36483953 |
| 60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.35363787 |
| 61 | Short middle phalanx of the 5th finger (HP:0004220) | 2.30741061 |
| 62 | Chromsome breakage (HP:0040012) | 2.29593744 |
| 63 | Abnormality of chromosome stability (HP:0003220) | 2.28730962 |
| 64 | Nephronophthisis (HP:0000090) | 2.27732173 |
| 65 | Volvulus (HP:0002580) | 2.24543736 |
| 66 | Muscle fiber atrophy (HP:0100295) | 2.21284594 |
| 67 | Abnormality of the labia minora (HP:0012880) | 2.20843560 |
| 68 | Poor coordination (HP:0002370) | 2.19613804 |
| 69 | Abnormal number of erythroid precursors (HP:0012131) | 2.18434930 |
| 70 | Febrile seizures (HP:0002373) | 2.17847366 |
| 71 | Emotional lability (HP:0000712) | 2.15016133 |
| 72 | Unsteady gait (HP:0002317) | 2.13420023 |
| 73 | CNS demyelination (HP:0007305) | 2.12165608 |
| 74 | Thyroiditis (HP:0100646) | 2.09897422 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.09643756 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.09643756 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09643756 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09643756 |
| 79 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.07274565 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.03917691 |
| 81 | Abnormality of the pons (HP:0007361) | 2.03177497 |
| 82 | Congenital, generalized hypertrichosis (HP:0004540) | 2.03001672 |
| 83 | CNS hypomyelination (HP:0003429) | 2.02929802 |
| 84 | Exertional dyspnea (HP:0002875) | 2.02634845 |
| 85 | Pancreatic cysts (HP:0001737) | 2.01849827 |
| 86 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01405536 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 1.99885034 |
| 88 | Oral leukoplakia (HP:0002745) | 1.99248228 |
| 89 | True hermaphroditism (HP:0010459) | 1.98932063 |
| 90 | Severe visual impairment (HP:0001141) | 1.95138365 |
| 91 | Absence seizures (HP:0002121) | 1.93229805 |
| 92 | Genital tract atresia (HP:0001827) | 1.92392563 |
| 93 | Metaphyseal dysplasia (HP:0100255) | 1.92089159 |
| 94 | Vaginal atresia (HP:0000148) | 1.91723246 |
| 95 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.91561959 |
| 96 | Macrocytic anemia (HP:0001972) | 1.91177790 |
| 97 | Postnatal microcephaly (HP:0005484) | 1.91017160 |
| 98 | Neutropenia (HP:0001875) | 1.89876246 |
| 99 | Hypoplasia of the pons (HP:0012110) | 1.89381094 |
| 100 | Inability to walk (HP:0002540) | 1.89191400 |
| 101 | Gaze-evoked nystagmus (HP:0000640) | 1.87789758 |
| 102 | Attenuation of retinal blood vessels (HP:0007843) | 1.87757063 |
| 103 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.87293135 |
| 104 | Lethargy (HP:0001254) | 1.86881930 |
| 105 | Stomach cancer (HP:0012126) | 1.86331449 |
| 106 | IgM deficiency (HP:0002850) | 1.85971746 |
| 107 | Abnormality of homocysteine metabolism (HP:0010919) | 1.84648891 |
| 108 | Homocystinuria (HP:0002156) | 1.84648891 |
| 109 | Degeneration of anterior horn cells (HP:0002398) | 1.84571954 |
| 110 | Abnormality of the anterior horn cell (HP:0006802) | 1.84571954 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.84398824 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 1.84077893 |
| 113 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84014052 |
| 114 | Delusions (HP:0000746) | 1.83919350 |
| 115 | Short tibia (HP:0005736) | 1.83465770 |
| 116 | Premature graying of hair (HP:0002216) | 1.83385682 |
| 117 | Breast hypoplasia (HP:0003187) | 1.82370133 |
| 118 | Reduced antithrombin III activity (HP:0001976) | 1.82111038 |
| 119 | Abnormality of vitamin B metabolism (HP:0004340) | 1.81938011 |
| 120 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.81255651 |
| 121 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79566465 |
| 122 | Small intestinal stenosis (HP:0012848) | 1.79411922 |
| 123 | Duodenal stenosis (HP:0100867) | 1.79411922 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.77637640 |
| 125 | Absent/shortened dynein arms (HP:0200106) | 1.77637640 |
| 126 | Visual hallucinations (HP:0002367) | 1.76016477 |
| 127 | Increased muscle lipid content (HP:0009058) | 1.75882293 |
| 128 | X-linked dominant inheritance (HP:0001423) | 1.74502702 |
| 129 | Abnormality of the prostate (HP:0008775) | 1.72540753 |
| 130 | Intestinal atresia (HP:0011100) | 1.72323916 |
| 131 | Progressive inability to walk (HP:0002505) | 1.72142284 |
| 132 | Fair hair (HP:0002286) | 1.71994361 |
| 133 | Sloping forehead (HP:0000340) | 1.71058419 |
| 134 | Dialeptic seizures (HP:0011146) | 1.70444422 |
| 135 | Large for gestational age (HP:0001520) | 1.70274901 |
| 136 | Rough bone trabeculation (HP:0100670) | 1.69767709 |
| 137 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.69055470 |
| 138 | Patchy hypopigmentation of hair (HP:0011365) | 1.68788262 |
| 139 | Gliosis (HP:0002171) | 1.67778545 |
| 140 | Pancytopenia (HP:0001876) | 1.65373404 |
| 141 | Abnormality of renal resorption (HP:0011038) | 1.64618765 |
| 142 | Microretrognathia (HP:0000308) | 1.63797446 |
| 143 | Limb dystonia (HP:0002451) | 1.63253466 |
| 144 | Protruding tongue (HP:0010808) | 1.62934801 |
| 145 | Agnosia (HP:0010524) | 1.54724302 |
| 146 | Broad foot (HP:0001769) | 1.54554315 |
| 147 | Supernumerary spleens (HP:0009799) | 1.53443026 |
| 148 | White forelock (HP:0002211) | 1.52974767 |
| 149 | Abnormality of the columella (HP:0009929) | 1.52228495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.22556436 |
| 2 | CASK | 3.69043452 |
| 3 | FRK | 3.27542707 |
| 4 | BUB1 | 3.15184627 |
| 5 | MAP3K12 | 3.03399617 |
| 6 | EIF2AK1 | 2.80477706 |
| 7 | MAP4K2 | 2.64113887 |
| 8 | TSSK6 | 2.61851566 |
| 9 | TAOK3 | 2.57796373 |
| 10 | WEE1 | 2.56138828 |
| 11 | EIF2AK3 | 2.37864254 |
| 12 | ACVR1B | 2.34871648 |
| 13 | CCNB1 | 2.33882107 |
| 14 | MAP2K7 | 2.32878337 |
| 15 | CDC7 | 2.08674958 |
| 16 | TNIK | 2.08290134 |
| 17 | MKNK2 | 2.05761486 |
| 18 | VRK1 | 2.01918460 |
| 19 | SRPK1 | 1.95057039 |
| 20 | MKNK1 | 1.94990082 |
| 21 | ERBB3 | 1.81479674 |
| 22 | PLK2 | 1.69080484 |
| 23 | DAPK1 | 1.60159101 |
| 24 | BRSK2 | 1.59736086 |
| 25 | CDK19 | 1.56332197 |
| 26 | NME1 | 1.53824893 |
| 27 | AKT3 | 1.51986449 |
| 28 | PRPF4B | 1.36127767 |
| 29 | TRIM28 | 1.32424047 |
| 30 | PLK3 | 1.31753377 |
| 31 | SIK3 | 1.23277932 |
| 32 | NTRK3 | 1.23046217 |
| 33 | BRAF | 1.22562115 |
| 34 | ARAF | 1.20197963 |
| 35 | PDK3 | 1.14721824 |
| 36 | PDK4 | 1.14721824 |
| 37 | BRSK1 | 1.12941072 |
| 38 | MAPK13 | 1.12783682 |
| 39 | ADRBK2 | 1.12492522 |
| 40 | MYLK | 1.12012355 |
| 41 | MAP3K4 | 1.08062454 |
| 42 | VRK2 | 1.06246085 |
| 43 | PLK4 | 1.03328784 |
| 44 | MUSK | 1.00133650 |
| 45 | BCR | 0.98992659 |
| 46 | GRK1 | 0.96565452 |
| 47 | MST4 | 0.96274925 |
| 48 | BMPR1B | 0.95964842 |
| 49 | PIM2 | 0.91126380 |
| 50 | NME2 | 0.89825029 |
| 51 | TXK | 0.88956603 |
| 52 | CLK1 | 0.85101547 |
| 53 | PLK1 | 0.82991591 |
| 54 | RPS6KA5 | 0.79515388 |
| 55 | NEK1 | 0.78337841 |
| 56 | BMPR2 | 0.78278764 |
| 57 | PRKCG | 0.77706794 |
| 58 | YES1 | 0.77118805 |
| 59 | OXSR1 | 0.76787513 |
| 60 | MINK1 | 0.76337187 |
| 61 | GRK5 | 0.74225278 |
| 62 | FES | 0.72195435 |
| 63 | NEK6 | 0.70682139 |
| 64 | ATR | 0.69627599 |
| 65 | AURKA | 0.68330738 |
| 66 | ZAK | 0.68114687 |
| 67 | EPHA4 | 0.67574906 |
| 68 | PDK2 | 0.64871244 |
| 69 | CSNK1G1 | 0.64497858 |
| 70 | TLK1 | 0.63360101 |
| 71 | PNCK | 0.63155059 |
| 72 | CAMK2B | 0.62138353 |
| 73 | PAK3 | 0.62117877 |
| 74 | CSNK1A1L | 0.60142024 |
| 75 | PASK | 0.59469505 |
| 76 | PINK1 | 0.58167587 |
| 77 | EIF2AK2 | 0.57787422 |
| 78 | IKBKB | 0.57692304 |
| 79 | CSNK1G3 | 0.57289987 |
| 80 | * CSNK2A1 | 0.56308726 |
| 81 | TNK2 | 0.55423873 |
| 82 | STK39 | 0.54529941 |
| 83 | RAF1 | 0.54327050 |
| 84 | BRD4 | 0.54087665 |
| 85 | CDK18 | 0.53760727 |
| 86 | ATM | 0.53067736 |
| 87 | KIT | 0.51654359 |
| 88 | MAPKAPK5 | 0.51440284 |
| 89 | BCKDK | 0.51168984 |
| 90 | ITK | 0.50354276 |
| 91 | TEC | 0.50241043 |
| 92 | PIK3CA | 0.49379446 |
| 93 | * CSNK2A2 | 0.48506873 |
| 94 | CAMKK2 | 0.48216267 |
| 95 | CAMK2A | 0.47690779 |
| 96 | ADRBK1 | 0.47516053 |
| 97 | PIM1 | 0.47427277 |
| 98 | CDK14 | 0.47406131 |
| 99 | STK38L | 0.47174463 |
| 100 | PKN1 | 0.46883897 |
| 101 | RPS6KB1 | 0.46303376 |
| 102 | CDK3 | 0.45709828 |
| 103 | PRKCE | 0.45556159 |
| 104 | LIMK1 | 0.45259635 |
| 105 | INSRR | 0.44325310 |
| 106 | CDK15 | 0.43531349 |
| 107 | AURKB | 0.42914846 |
| 108 | GRK7 | 0.42603808 |
| 109 | PIK3CG | 0.42224714 |
| 110 | TRPM7 | 0.40873160 |
| 111 | CDK11A | 0.40871182 |
| 112 | TTK | 0.40815623 |
| 113 | DYRK1A | 0.40628387 |
| 114 | ERBB4 | 0.39097988 |
| 115 | CHEK2 | 0.39020577 |
| 116 | DYRK3 | 0.38667859 |
| 117 | DYRK2 | 0.37164499 |
| 118 | STK4 | 0.36741628 |
| 119 | NLK | 0.35833604 |
| 120 | RPS6KA4 | 0.35645752 |
| 121 | CAMK2G | 0.35338478 |
| 122 | ILK | 0.35119871 |
| 123 | IKBKE | 0.34736493 |
| 124 | TAOK2 | 0.34521740 |
| 125 | MARK1 | 0.34337669 |
| 126 | IRAK1 | 0.33680322 |
| 127 | WNK3 | 0.33492042 |
| 128 | PBK | 0.33449800 |
| 129 | CSNK1G2 | 0.33065453 |
| 130 | MARK3 | 0.31721649 |
| 131 | NUAK1 | 0.31270344 |
| 132 | MAP2K4 | 0.31231149 |
| 133 | CAMK2D | 0.30893473 |
| 134 | CDK7 | 0.30739990 |
| 135 | SYK | 0.30295102 |
| 136 | IGF1R | 0.29702671 |
| 137 | EPHA3 | 0.29148451 |
| 138 | LCK | 0.29048838 |
| 139 | PRKG1 | 0.26453453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.21867255 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.67726972 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.49114842 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.44687263 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.23260676 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.18440492 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.69489118 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.61950410 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.61232722 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.40495683 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.40244709 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.31663018 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.25941251 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.24561784 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18143691 |
| 16 | * Nucleotide excision repair_Homo sapiens_hsa03420 | 2.14359597 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.99975127 |
| 18 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96650513 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94086568 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.93756980 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.90195346 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.72423982 |
| 23 | * Basal transcription factors_Homo sapiens_hsa03022 | 1.69797193 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68174200 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67089834 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.63372308 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.62219977 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.62020106 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46373638 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.46020815 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40689094 |
| 32 | * Cell cycle_Homo sapiens_hsa04110 | 1.31081338 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20791083 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20258090 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16660207 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15031690 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12918204 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.11692887 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06345690 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05877629 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98961768 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.98845307 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97713284 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97170996 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93938349 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92599574 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91418108 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90042273 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85569700 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85476605 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84659413 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84427356 |
| 53 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.82955031 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.82445819 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.80595440 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.79260071 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77370629 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77343094 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74998464 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74751888 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73890060 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73334363 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.72854380 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 0.72782146 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72245831 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71690404 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70915454 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68226944 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67663699 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66544711 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66223063 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66126573 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66073022 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66022184 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65568860 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64776011 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64397497 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63882933 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.62711805 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60699268 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60430848 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59628805 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58542891 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56759673 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.55596490 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54700753 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53009825 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52084383 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51284381 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50886655 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50816616 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50487975 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50395308 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49233762 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49199670 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48276808 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.46000631 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.43952800 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43655976 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42714865 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39935995 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39022692 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38397348 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37912159 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37456110 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.37400439 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36697879 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35568010 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34449718 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33591011 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33447309 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33007901 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32658169 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.31905290 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31829539 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29787211 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26156654 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25708936 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.24052773 |
| 120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.24028563 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.23448185 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21580906 |
| 123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21170018 |
| 124 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20505740 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20159934 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18952253 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18397715 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17595272 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15728236 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.14549276 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13102569 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13046045 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12904110 |
| 134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.11673478 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.09293996 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.08746055 |
| 137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08635685 |

